The relationships among diabetes mellitus (DM), brainstem infarctions (BSIs) and involvement of the basilar artery (BA) were investigated in 254 patients with acute cerebral infarctions detected on magnetic resonance (MR) imaging. Radiological findings included lesion topography and size (mm2) of BSIs on MR images, and the extent of BA stenosis measured by MR angiography. Adjusted logistic regression analyses showed that DM (OR 4.018; p = 0.0006) and BA stenosis (OR 1.003 per 1 mm; p < 0.0001) had an independent association with the incidence of BSIs, but the lesion size of the BSIs was only associated with BA stenosis (β coefficient 0.280; p < 0.0001). Diabetic patients showed significantly more frequent isolated pontine infarctions and a lesser degree of BA stenosis (p < 0.005) compared to non-diabetic patients. Preferential involvement of the pons and smaller vessels may be characteristics of diabetic patients.

Keywords:
Stenosis, Basilar artery, Magnetic resonance imaging, Brainstem infarction, Diabetes mellitus
1.
Kitaguchi H, Tomimoto H, Miki Y, Yamamoto A, Terada K, Satoi H, Kanda M, Fukuyama H: A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 2005;47:652–656.
2.
Kumai Y, Toyoda K, Fukui K, Ibayashi S: Hypertensive encephalopathy extending into the whole brainstem and deep structures. Hypertens Res 2002;25:797–800.
3.
Thambisetty M, Biousse V, Newman NJ: Hypertensive brainstem encephalopathy: clinical and radiographic features. J Neurol Sci 2003;15:93–99.
4.
Aronson SM: Intracranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol 1973;32:183–196.
5.
Peress NS, Kane WC, Aronson SM: Central nervous system findings in a tenth decade autopsy population. Prog Brain Res 1973;40:473–478.
6.
Kameyma M, Fushimi F, Udaka F: Diabetes and cerebral vascular disease. Diabetes Res Clin Pract 1994;24:S205–S208.
7.
Nakase T, Yamamoto Y, Ooiwa K, Hayashi M, Nakajima K: Diabetes mellitus and ischemic stroke: ischemic stroke topography for diabetes mellitus. Jpn J Stroke 2000;22:335–342.
8.
Iwase M, Yamamoto M, Yoshinari M, Ibayashi S, Fujishima M: Stroke topography in diabetic and nondiabetic patients by magnetic resonance imaging. Diabetes Res Clin Pract 1998;42:109–116.
9.
Karapanayiotides T, Piechowski-Jozwiak P, van Melle G, Bogousslavsky J, Devuyst G: Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 2004;62:1558–1562.
10.
Uluduz D, Ince B, Bozloulcay M: Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Stroke 2005;64:581–582.
11.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR: revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–992.
12.
Kameda W, Kawanami T, Kurita K, Damian M, Kayama T, Hosoya T, Kato T: Lateral and medial medullary infarction. Stroke 2004;35:694–699.
13.
Kunz S, Griese H, Busse O: Etiology and long-term prognosis of unilateral paramedian pontine infarction with progressive symptoms. Eur Neurol 2003;50:136–140.
14.
Fisher CM, Caplan LR: Basilar artery branch occlusion: a cause of pontine infarction. Neurology 1971;21:900–905.
15.
Fisher CM: Bilateral occlusion of basilar artery branches. J Neurol Neurosurg Psychiatry 1977;40:1182–1189.
16.
Ichikawa H, Mukai M, Takahashi N, Katoh H, Kuriki A, Kawamura M: Dilative arterial remodeling of the brain with different effects on the anterior and posterior circulation: an MRI study. J Neurol Sci 2009;287:236–240.
17.
Beausang-Linder M, Bill A: Cerebral circulation in acute arterial hypertension: protective effects of symptomatic nervous activity. Acta Physiol Scand 1981;111:193–199.
18.
Edvinsson L, Owman C, Sjoberg NO: Autonomic nerves, mast cells, and amine receptors in human brain vessels: histochemical and pharmacologic study. Brain Res 1976;115:377–393.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.